Sean Bohen
2023
In 2023, Sean Bohen earned a total compensation of $3.2M as President and Chief Executive Officer at Olema Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $489,000 |
---|---|
Option Awards | $2,002,000 |
Salary | $647,000 |
Other | $14,370 |
Total | $3,152,370 |
Bohen received $2M in option awards, accounting for 64% of the total pay in 2023.
Bohen also received $489K in non-equity incentive plan, $647K in salary and $14.4K in other compensation.
Rankings
In 2023, Sean Bohen's compensation ranked 271st out of 2,647 executives tracked by ExecPay. In other words, Bohen earned more than 89.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 271 | 90th |
Manufacturing | 147 | 90th |
Chemicals And Allied Products | 101 | 88th |
Drugs | 98 | 88th |
Pharmaceutical Preparations | 62 | 89th |
Bohen's colleagues
We found three more compensation records of executives who worked with Sean Bohen at Olema Pharmaceuticals in 2023.